Sei Investments CO Neurocrine Biosciences Inc Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sei Investments CO holds 155,119 shares of NBIX stock, worth $19.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

155,119

Previous 128,016 21.17%

Holding current value

$19.5 Million

Previous $17.6 Million 1.33%

% of portfolio

0.02%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $3.11 Million - $4.15 Million	27,103 Added 21.17%	155,119 $17.9 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $5.41 Million - $5.92 Million	41,347 Added 47.71%	128,016 $17.6 Million
Q1 2024 May 07, 2024	SELL	$130.4 - $143.74 $3.82 Million - $4.21 Million	-29,289 Reduced 25.26%	86,669 $12 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $2.7 Million - $3.37 Million	25,416 Added 28.07%	115,958 $15.3 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $4,418 - $5,503	-47 Reduced 0.05%	90,542 $10.2 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $574,514 - $672,950	6,417 Added 7.62%	90,589 $8.54 Million
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $2.66 Million - $3.48 Million	-28,311 Reduced 25.17%	84,172 $8.52 Million
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $242,254 - $288,426	2,270 Added 2.06%	112,483 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $4.74 Million - $5.55 Million	51,512 Added 87.75%	110,213 $11.7 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $142,409 - $188,031	1,879 Added 3.31%	58,701 $5.66 Million
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $264,225 - $345,772	-3,647 Reduced 6.03%	56,822 $5.27 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $214,656 - $286,262	2,695 Added 4.66%	60,469 $5.11 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $7,583 - $8,714	88 Added 0.15%	57,774 $5.48 Million
Q2 2021 Aug 06, 2021	SELL	$89.43 - $102.27 $229,745 - $262,731	-2,569 Reduced 4.26%	57,686 $5.43 Million
Q1 2021 May 12, 2021	SELL	$87.57 - $119.4 $2.26 Million - $3.08 Million	-25,788 Reduced 29.97%	60,255 $5.73 Million
Q4 2020 Feb 08, 2021	BUY	$86.91 - $108.33 $1.64 Million - $2.04 Million	18,826 Added 28.01%	86,043 $8.13 Million
Q3 2020 Dec 04, 2020	SELL	$96.16 - $135.15 $25,770 - $36,220	-268 Reduced 0.4%	67,217 $6.37 Million
Q3 2020 Nov 06, 2020	SELL	$96.16 - $135.15 $537,342 - $755,218	-5,588 Reduced 7.65%	67,485 $6.4 Million
Q2 2020 Aug 17, 2020	SELL	$85.09 - $130.36 $617,668 - $946,283	-7,259 Reduced 9.04%	73,073 $8.72 Million
Q2 2020 Aug 11, 2020	BUY	$85.09 - $130.36 $881,787 - $1.35 Million	10,363 Added 14.81%	80,332 $8.5 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $454,791 - $688,816	-6,055 Reduced 7.96%	69,969 $6.05 Million
Q4 2019 Feb 06, 2020	SELL	$86.8 - $118.57 $169,260 - $231,211	-1,950 Reduced 2.5%	76,024 $8.17 Million
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $659,160 - $798,196	7,864 Added 11.22%	77,974 $7.03 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $1.23 Million - $1.56 Million	17,089 Added 32.23%	70,110 $5.92 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $4.03 Million - $5.33 Million	-58,204 Reduced 52.33%	53,021 $4.67 Million
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $116,553 - $212,158	1,706 Added 1.56%	111,225 $13.4 Million
Q3 2018 Nov 08, 2018	BUY	$98.88 - $125.85 $449,014 - $571,484	4,541 Added 4.33%	109,519 $13.5 Million
Q2 2018 Aug 03, 2018	SELL	$75.3 - $105.99 $542,084 - $763,022	-7,199 Reduced 6.42%	104,978 $10.3 Million
Q1 2018 May 11, 2018	SELL	$75.88 - $92.43 $1.6 Million - $1.95 Million	-21,127 Reduced 15.85%	112,177 $9.3 Million
Q4 2017 Feb 08, 2018	BUY	$58.53 - $77.59 $912,716 - $1.21 Million	15,594 Added 13.25%	133,304 $10.3 Million
Q3 2017 Nov 06, 2017	BUY	$47.97 - $61.28 $5.65 Million - $7.21 Million	117,710	117,710 $7.21 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Neurocrine Biosciences Inc Transaction History